ArticleBiomolecules2023

Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors.

Gabriela Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.